Published in Blood Weekly, January 31st, 2002
Yi Lin and colleagues at the University of Minnesota Medical School in Minneapolis and Emory University's Winship Cancer Center in Atlanta evaluated the safety and efficacy of such therapy in animals. The results of their study were published in the January 15, 2002 edition of the journal Blood.
Engineered BOACs successfully delivered therapeutic levels of a coagulation factor to mice, Lin and coauthors reported.
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Blood Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.